Comparative analysis between azacitidine and decitabine for the treatment of myelodysplastic syndromes

Summary The present study aimed to directly compare the efficacy and safety of azacitidine and decitabine in patients with myelodysplastic syndromes (MDS). We compared the overall response rate (ORR) (complete responses, partial responses, marrow complete responses, and haematological improvements),...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	British journal of haematology 2013-05, Vol.161 (3), p.339-347
Hauptverfasser:	Lee, Yun‐Gyoo, Kim, Inho, Yoon, Sung‐Soo, Park, Seonyang, Cheong, June Won, Min, Yoo Hong, Lee, Jeong‐Ok, Bang, Soo‐Mee, Yi, Hyeon Gyu, Kim, Chul Soo, Park, Yong, Kim, Byung‐Soo, Mun, Yeung‐Chul, Seong, Chu‐Myoung, Park, Jinny, Lee, Jae Hoon, Kim, Sung‐Yong, Lee, Hong Ghi, Kim, Yeo‐Kyeoung, Kim, Hyeoung‐Joon
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Adult Aged Aged, 80 and over Antimetabolites - adverse effects Antimetabolites - therapeutic use azacitidine Azacitidine - adverse effects Azacitidine - analogs & derivatives Azacitidine - therapeutic use Biological and medical sciences Bone Marrow Examination comparison decitabine Disease-Free Survival Female Hematologic and hematopoietic diseases Humans Infection Control Kaplan-Meier Estimate Karyotyping Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis Male Medical sciences Middle Aged myelodysplastic syndromes Myelodysplastic Syndromes - classification Myelodysplastic Syndromes - drug therapy Myelodysplastic Syndromes - genetics Myelodysplastic Syndromes - pathology Neutropenia - chemically induced Research Design Retrospective Studies Risk Assessment Treatment Outcome Tumors Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!